poisar

Stocks · News reference

Kestra Medical Technologies Announces Publication of ACE-PAS Study Results

Fiscal.ai

Kestra Medical Technologies has published primary results from the ASSURE WCD Clinical Evaluation Post-Approval Study (ACE-PAS), the largest prospective real-world study of wearable cardioverter defibrillators to date.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading